請輸入關鍵字
請輸入關鍵字
訂購
*國家
中國
美國
中國香港
中國澳門
中國台灣
阿爾巴尼亞
阿爾及利亞
阿根廷
阿拉伯聯合酋長國
阿魯巴
阿曼
阿塞拜疆
阿森鬆島
埃及
埃塞俄比亞
愛爾蘭
愛沙尼亞
安道爾
安哥拉
安圭拉
安提瓜和巴布達
奧地利
奧蘭群島
澳大利亞
巴巴多斯
巴布亞新幾內亞
巴哈馬
巴基斯坦
巴拉圭
巴勒斯坦領土
巴林
巴拿馬
巴西
白俄羅斯
百慕大
保加利亞
北馬裏亞納群島
貝寧
比利時
冰島
波多黎各
波蘭
波斯尼亞和黑塞哥維那
玻利維亞
伯利茲
博茨瓦納
不丹
布基納法索
布隆迪
朝鮮
赤道幾內亞
丹麥
德國
迪戈加西亞島
東帝汶
多哥
多米尼加共和國
多米尼克
俄羅斯
厄瓜多爾
厄立特裏亞
法國
法羅群島
法屬波利尼西亞
法屬圭亞那
法屬南部領地
梵蒂岡
菲律賓
斐濟
芬蘭
佛得角
福克蘭群島
岡比亞
剛果(布)
剛果(金)
哥倫比亞
哥斯達黎加
格恩西島
格林納達
格陵蘭
格魯吉亞
古巴
瓜德羅普
關島
圭亞那
哈薩克斯坦
海地
韓國
荷蘭
荷屬加勒比區
荷屬聖馬丁
黑山
洪都拉斯
基裏巴斯
吉布提
吉爾吉斯斯坦
幾內亞
幾內亞比紹
加拿大
加納
加納利群島
加蓬
柬埔寨
捷克
津巴布韋
喀麥隆
卡塔爾
開曼群島
科科斯(基林)群島
科摩羅
科索沃
科特迪瓦
科威特
克羅地亞
肯尼亞
庫克群島
庫拉索
拉脫維亞
萊索托
老撾
黎巴嫩
立陶宛
利比裏亞
利比亞
聯合國
列支敦士登
留尼汪
盧森堡
盧旺達
羅馬尼亞
馬達加斯加
馬恩島
馬爾代夫
馬耳他
馬拉維
馬來西亞
馬裏
馬其頓
馬紹爾群島
馬提尼克
馬約特
毛裏求斯
毛裏塔尼亞
美國本土外小島嶼
美屬薩摩亞
美屬維爾京群島
蒙古
蒙特塞拉特
孟加拉國
秘魯
密克羅尼西亞
緬甸
摩爾多瓦
摩洛哥
摩納哥
莫桑比克
墨西哥
納米比亞
南非
南極洲
南喬治亞和南桑威奇群島
南蘇丹
瑙魯
尼加拉瓜
尼泊爾
尼日爾
尼日利亞
紐埃
挪威
諾福克島
帕勞
皮特凱恩群島
葡萄牙
日本
瑞典
瑞士
薩爾瓦多
薩摩亞
塞爾維亞
塞拉利昂
塞內加爾
塞浦路斯
塞舌爾
沙特阿拉伯
聖巴泰勒米
聖誕島
聖多美和普林西比
聖赫勒拿
聖基茨和尼維斯
聖盧西亞
聖馬丁島
聖馬力諾
聖皮埃爾和密克隆群島
聖文森特和格林納丁斯
斯裏蘭卡
斯洛伐克
斯洛文尼亞
斯瓦爾巴和揚馬延
斯威士蘭
蘇丹
蘇裏南
所羅門群島
索馬裏
塔吉克斯坦
泰國
坦桑尼亞
湯加
特克斯和凱科斯群島
特裏斯坦-達庫尼亞群島
特立尼達和多巴哥
突尼斯
圖瓦盧
土耳其
土庫曼斯坦
托克勞
瓦利斯和富圖納
瓦努阿圖
危地馬拉
委內瑞拉
文萊
烏幹達
烏克蘭
烏拉圭
烏茲別克斯坦
希臘
西班牙
西撒哈拉
新加坡
新喀裏多尼亞
新西蘭
匈牙利
休達及梅利利亞
敘利亞
牙買加
亞美尼亞
也門
伊拉克
伊朗
以色列
意大利
印度
印度尼西亞
英國
英屬維爾京群島
英屬印度洋領地
約旦
越南
讚比亞
澤西島
乍得
直布羅陀
智利
中非共和國
*省份
*城市
*姓名
*電話
*單位
*職位
*郵箱
*請輸入驗證碼
*驗證碼
B-hCD16A mice plus(CB-17 SCID)
Strain Name
CB17/lcr-PrkdcscidFcgr4tm2(FCGR3A)Bcgen/Bcgen 
Common Name  B-hCD16A mice plus(CB-17 SCID)
Background CB-17 SCID Catalog number  113688
Aliases 

CD16, FCG3, CD16A, FCGR3, IGFR3, IMD20, 

FCR-10, FCRIII, CD16-II, FCGRIII, FCRIIIA, FcGRIIIA

NCBI Gene ID
2214
Description

  • Mouse FcγRIV, also known as CD16.2, is an intermediate-affinity activating receptor for IgG2a and IgG2b. CD16.2 is the mouse homolog of human FcγRIIIA. CD16.2 expressed on the surface of monocytes, macrophages, and neutrophils. CD16.2 is a low-affinity IgE receptor for all allotypes and the ligation of FcγRIV by antigen-IgE immune complexes promotes macrophage-mediated phagocytosis and is involved in lung inflammation.
  • Human FcγRIII, also known as CD16, is a low affinity IgG Fc receptor for a broad range of different isotypes. It primarily exists as two distinct forms: Fcγ RIIIA/ CD16a and Fcγ RIIIB/ CD16b, which are encoded by two nearly identical genes in humans. Fcγ RIIIA is a 50-65 kD type I transmembrane protein that is expressed on the surface of NK cells, monocytes, macrophages, and placental trophoblasts in humans. Fcγ RIIIA can bind aggregated IgG or IgG-antigen complex which functions in NK cell activation, phagocytosis, and antibody-dependent cell-mediated cytotoxicity (ADCC). 
  • The exons 1-5 of mouse Fcgr4 gene that encode extracellular domain are replaced by human counterparts in B-hCD16A mice plus(CB-17 SCID). The genomic region of mouse Fcgr4 gene that encodes transmembrane and cytoplasmic portion is retained. The promoter and 5’UTR region of the mouse gene are replaced by human counterparts. The chimeric CD16A expression is driven by endogenous human CD16A promoter, while mouse Fcgr4 gene transcription and translation will be disrupted. 
  • Human CD16A was detectable in NK cells, DCs, monocytes and macrophages of B-hCD16A mice plus(CB-17 SCID).

Protein expression analysis in spleen NK cells


from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A mice plus(CB-17 SCID) by flow cytometry. Splenocytes were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A mice plus(CB-17 SCID) (H/H). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was not detectable in NK cells of wild-type CB-17 SCID mice. Human CD16A was detectable in NK cells of homozygous B-hCD16A mice plus(CB-17 SCID), but not in wild-type CB-17 SCID mice.


Protein expression analysis in spleen DCs

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A mice plus(CB-17 SCID) by flow cytometry. Splenocytes were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A mice plus(CB-17 SCID) (H/H). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was detectable in DCs of wild-type CB-17 SCID mice. Human CD16A was detectable in DCs of homozygous B-hCD16A mice plus(CB-17 SCID), but not in wild-type CB-17 SCID mice.


Protein expression analysis in spleen monocytes

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A mice plus(CB-17 SCID) by flow cytometry. Splenocytes were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A mice plus(CB-17 SCID) (H/H). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was weakly detectable in monocytes of wild-type CB-17 SCID mice. Human CD16A was detectable in monocytes of homozygous B-hCD16A mice plus(CB-17 SCID), but not in wild-type CB-17 SCID mice.


Protein expression analysis in spleen macrophages

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A mice plus(CB-17 SCID) by flow cytometry. Splenocytes were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A mice plus(CB-17 SCID) (H/H). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was detectable in macrophages of wild-type CB-17 SCID mice. Human CD16A was detectable in macrophages of homozygous B-hCD16A mice plus(CB-17 SCID), but not in wild-type CB-17 SCID mice.


Protein expression analysis in spleen neutrophils

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A mice plus(CB-17 SCID) by flow cytometry. Splenocytes were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A mice plus(CB-17 SCID) (H/H). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was detectable in neutrophils of wild-type CB-17 SCID mice. Human CD16A was not detectable in neutrophils of homozygous B-hCD16A mice plus(CB-17 SCID).


Protein expression analysis in blood NK cells

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A mice plus(CB-17 SCID) by flow cytometry. Blood were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A mice plus(CB-17 SCID) (H/H). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was not detectable in NK cells of wild-type CB-17 SCID mice. Human CD16A was detectable in NK cells of homozygous B-hCD16A mice plus(CB-17 SCID), but not in wild-type CB-17 SCID mice.


Protein expression analysis in blood monocytes

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A mice plus(CB-17 SCID) by flow cytometry. Blood were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A mice plus(CB-17 SCID) (H/H). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was not detectable in monocytes of wild-type CB-17 SCID mice. Human CD16A was detectable in monocytes of homozygous B-hCD16A mice plus(CB-17 SCID), but not in wild-type CB-17 SCID mice.


Protein expression analysis in blood macrophages

from clipboard

Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A mice plus(CB-17 SCID) by flow cytometry. Blood were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A mice plus(CB-17 SCID) (H/H). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was detectable in macrophages of wild-type CB-17 SCID mice. Human CD16A was detectable in macrophages of homozygous B-hCD16A mice plus(CB-17 SCID), but not in wild-type CB-17 SCID mice.


Protein expression analysis in blood neutrophils

from clipboard



Strain specific CD16A expression analysis in wild-type CB-17 SCID mice and homozygous B-hCD16A mice plus(CB-17 SCID) by flow cytometry. Blood were collected from wild-type CB-17 SCID mice (+/+) and homozygous B-hCD16A mice plus(CB-17 SCID) (H/H). Protein expression was analyzed with anti-mouse CD16.2 (FcγRIV) antibody (Biolegend, 149503) and anti-human CD16 antibody (Biolegend, 302008) by flow cytometry. Mouse CD16A was detectable in neutrophils of wild-type CB-17 SCID mice. Human CD16A was not detectable in neutrophils of homozygous B-hCD16A mice plus(CB-17 SCID).